Nano-X Imaging Q3 revenue grows on AI solutions; flags going concern issues

Nano-X Imaging

16/10/2026 21:26

Overview
Israel medical imaging tech firm's preliminary Q3 revenue rose yr/yr
Company's AI and software solutions revenue grew, driven by consolidation of Nanox Health IT Inc.
Company warns cash levels raise substantial doubt about ability to continue as a going concern

Outlook
Company expects cash and deposits as of Sept 30, 2026, are not sufficient for one year
Company expects to continue to incur significant costs related to ongoing operations
Company may delay, reduce or eliminate product development if unable to raise additional funds

Result Drivers
AI AND SOFTWARE SOLUTIONS - Revenue growth driven mainly by consolidation of Nanox Health IT Inc.
IMAGING SYSTEM SALES - Higher imaging system and OEM services revenue attributed to additional Nanox.ARC CapEx agreement
TELERADIOLOGY SERVICES - Teleradiology revenue remained flat yr/yr at $3.1 mln

Company press release: ID:nGNX5M0l89

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
$4.3-$4.4 mln

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Nano-X Imaging Ltd is $4.40, about 795.9% above its October 15 closing price of $0.49

Reuters Recommended Reads
Oct 15 - CoreWeave's slump spotlights growing burden of debt behind AI boom
Oct 15 - France's Pernod Ricard Q1 sales fall marginally, flags weakness in US and China markets

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)